Influence of ethnic origin (Asian v. Caucasian) and background diet on the bioavailability of dietary isoflavones

British Journal of Nutrition

Volumn 102, Issue 11, 2009, Pages 1642-1653

  Vergne, Sbastien ^a,b,c   Sauvant, Patrick ^a,c   Lamothe, Valérie ^a,c   Chantre, Philippe ^b   Asselineau, Julien ^d   Perez, Paul ^d   Durand, Marlène ^e   Moore, Nicholas ^a   Bennetau Pelissero, Catherine ^a,c  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b Laboratoires Pharmaceutiques   (France)

^c ENITA de Bordeaux   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e INSERM   (France)

Author keywords

Asians; Caucasians; Pharmacokinetics; Soya isoflavones

Indexed keywords

DAIDZEIN; GENISTEIN; ISOFLAVONE;

ADULT; ARTICLE; ASIAN; BIOAVAILABILITY; BLOOD LEVEL; CAUCASIAN; CHEESE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; ETHNIC DIFFERENCE; GASTROINTESTINAL ABSORPTION; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SOYBEAN;

EID: 73749083601     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114509990833     Document Type: Article

References (42)

1. Cassidy A, Brown JE, Hawdon A, et al. (2006) Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr 136, 45-51.
2. Nielsen IL & Williamson G (2007) Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer 57, 1-10.
3. Rowland I, Faughnan M, Hoey L, et al. (2003) Bioavailability of phyto-oestrogens. Br J Nutr 89, Suppl. 1, S45-S58.
4. Arai Y, Watanabe S, Kimira M, et al. (2000) Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J Nutr 130, 2243-2250.
5. Kimira M, Arai Y, Shimoi K, et al. (1998) Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol 8, 168-175.
6. Nagata C, Shimizu H, Takami R, et al. (2002) Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporos Int 13, 200-204.
7. Liu Z, Li W, Sun J, et al. (2004) Intake of soy foods and soy isoflavones by rural adult women in China. Asia Pac J Clin Nutr 13, 204-209.
8. Mei J, Yeung SS & Kung AW (2001) High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin Endocrinol Metab 86, 5217-5221.
9. Surh J, Kim MJ, Koh E, et al. (2006) Estimated intakes of isoflavones and coumestrol in Korean population. Int J Food Sci Nutr 57, 325-344.
10. Keinan-Boker L, Peeters PH, Mulligan AA, et al. (2002) Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. Public Health Nutr 5, 1217-1226.
11. Bennetau-Pelissero C, Arnal-Schnebelen B, Lamothe V, et al. (2003) ELISA as a new method to measure genistein and daidzein in food and human fluids. Food Chem 82, 645-658.
12. Rannikko A, Petas A, Rannikko S, et al. (2006) Plasma and prostate phytoestrogen concentrations in prostate cancer patients after oral phytoestogen supplementation. Prostate 66, 82-87. (Pubitemid 43005951)
13. Gooderham MH, Adlercreutz H, Ojala ST, et al. (1996) A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 126, 2000-2006.
14. Adlercreutz H, Markkanen H & Watanabe S (1993) Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342, 1209-1210.
15. Klotz U (2007) The role of pharmacogenetics in the metabolism of antiepileptic drugs: pharmacokinetic and therapeutic implications. Clin Pharmacokinet 46, 271-279.
16. Alam AN, Saha JR, Dobkin JF, et al. (1988) Interethnic variation in the metabolic inactivation of digoxin by the gut flora. Gastroenterology 95, 117-123.
17. Messina M, Nagata C & Wu AH (2006) Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer 55, 1-12.
18. Chen ML (2006) Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 45, 957-964.
19. Lu LJ, Grady JJ, Marshall MV, et al. (1995) Altered time course of urinary daidzein and genistein excretion during chronic soya diet in healthy male subjects. Nutr Cancer 24, 311-323.
20. Mathey J, Lamothe V, Coxam V, et al. (2006) Concentrations of isoflavones in plasma and urine of post-menopausal women chronically ingesting high quantities of soy isoflavones. J Pharm Biomed Anal 41, 957-965.
21. Setchell KD, Faughnan MS, Avades T, et al. (2003) Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women. Am J Clin Nutr 77, 411-419.
22. Wiseman H, Casey K, Bowey EA, et al. (2004) Influence of 10 wk of soy consumption on plasma concentrations and excretion of isoflavonoids and on gut microflora metabolism in healthy adults. Am J Clin Nutr 80, 692-699.
23. Adlercreutz H, Honjo H, Higashi A, et al. (1991) Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am J Clin Nutr 54, 1093-1100.
24. Bennetau-Pelissero C, Le Houerou C, Lamothe V, et al. (2000) Synthesis of haptens and conjugates for ELISAs of phytoestrogens. Development of the immunological tests. J Agric Food Chem 48, 305-311.
25. Le Houerou C, Bennetau-Pelissero C, Lamothe V, et al. (2000) Syntheses of novel hapten-protein conjugates for production of highly specific antibodies to formononetin, daidzein and genistein. Tetrahedron 56, 295-301.
26. Bennetau-Pelissero C, Le Houerou C, Le Menn F, et al. (1998) ELISAs for genistein and daidzein. Cost 916 Bioactive Plant Cell Wall Components in Nutrition and Health. Phytoestrogens: Exposure, Bioavailability, Health Benefits and Safety Concerns, Doorweth, The Netherlands, April 17-18, pp. 55-62 [S Bausch-Goldbohm, A Kardinaal and F Serra, editors]. Luxembourg: European Communities.
27. Vergne S, Bennetau-Pelissero C, Lamothe V, et al. (2008) Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males. Br J Nutr 99, 333-344.
28. Vergne S, Titier K, Bernard V, et al. (2007) Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production. J Pharm Biomed Anal 43, 1488-1494.
29. Grizzle JE (1965) The two-period change-over design an its use in clinical trials. Biometrics 21, 467-480.
30. Nagel SC, vom Saal FS & Welshons WV (1998) The effective free fraction of estradiol and xenoestrogens in human serum measured by whole cell uptake assays: physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med 217, 300-309.
31. Pfeiffer E, Treiling CR, Hoehle SI, et al. (2005) Isoflavones modulate the glucuronidation of estradiol in human liver microsomes. Carcinogenesis 26, 2172-2178.
32. Richelle M, Pridmore-Merten S, et al. (2002) Hydrolysis of isoflavone glycosides to aglycones by beta-glycosidase does not alter plasma and urine isoflavone pharmacokinetics in postmenopausal women. J Nutr 132, 2587-2592.
33. Albert JD, Legaspi A, Horowitz GD, et al. (1986) Peripheral tissue metabolism in man with varied disease states and similar weight loss. J Surg Res 40, 374-381.
34. Setchell KD, Brown NM, Desai P, et al. (2001) Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 131, 1362S-1375S.
35. Watanabe S, Yamaguchi M, Sobue T, et al. (1998) Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr 128, 1710-1715.
36. Zheng Y, Hu J, Murphy PA, et al. (2003) Rapid gut transit time and slow fecal isoflavone disappearance phenotype are associated with greater genistein bioavailability in women. J Nutr 133, 3110-3116.
37. Atkinson C, Frankenfeld CL & Lampe JW (2005) Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood) 230, 155-170.
38. Uehar M, Arai Y, Watanabe S, et al. (2000) Comparison of plasma and urinary phytoestrogens in Japanese and Finnish women by time-resolved fluoroimmunoassay. Biofactors 12, 217-225.
39. Yamamoto S, Sobue T, Sasaki S, et al. (2001) Validity and reproducibility of a self-administered food-frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr 131, 2741-2747.
40. Morton MS, Arisaka O, Miyake N, et al. (2002) Phytoestrogen concentrations in serum from Japanese men and women over forty years of age. J Nutr 132, 3168-3171.
41. Ozasa K, Nakao M, Watanabe Y, et al. (2005) Association of serum phytoestrogen concentration and dietary habits in a sample set of the JACC Study. J Epidemiol 15, Suppl. 2, S196-S202. (Pubitemid 41410104)
42. Vedrine N, Mathey J, Morand C, et al. (2006) One-month exposure to soy isoflavones did not induce the ability to produce equol in postmenopausal women. Eur J Clin Nutr 60, 1039-1045.